Doxazosin Tablet
Product Images NDC 71335-2395

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 71335-2395). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Doxazosin Tablets, Usp (92ead971 9de8 4240 B2c7 Fc2e9abac7dd 01)

Doxazosin Tablets, Usp (92ead971 9de8 4240 B2c7 Fc2e9abac7dd 01)
Chemical structure diagram of the active ingredient Doxazosin, showing its molecular composition including rings, nitrogen, oxygen, and associated functional groups.*
FDA Label Image

Doxazosin Tablets (92ead971 9de8 4240 B2c7 Fc2e9abac7dd 02)

Doxazosin Tablets (92ead971 9de8 4240 B2c7 Fc2e9abac7dd 02)
A chart comparing symptom score and maximum flow rate (mL/sec) from three studies of Doxazosin treatment versus placebo. It includes mean baseline values and changes for symptom score and flow rate, with bar graphs illustrating significant improvements in maximum flow rate in Study 2 for 4 mg and 8 mg doses versus placebo.*
FDA Label Image

Doxazosin Tablets, Usp (92ead971 9de8 4240 B2c7 Fc2e9abac7dd 03)

Doxazosin Tablets, Usp (92ead971 9de8 4240 B2c7 Fc2e9abac7dd 03)
Two line graphs display clinical data comparing Doxazosin and placebo over 14 weeks. The first graph shows mean change in total symptom score from baseline, indicating greater symptom reduction with Doxazosin. The second graph illustrates mean increase in maximum urinary flow rate from baseline, showing higher urinary flow improvement with Doxazosin compared to placebo. Both graphs include error bars and statistical significance markers.*
FDA Label Image

Label (Lbl713352395)

Label (Lbl713352395)
Doxazosin Tablets, USP 2 mg oral tablets repackaged by Bryant Ranch Prepack, Inc. The label states each tablet contains Doxazosin Mesylate equivalent to 2 mg Doxazosin as free base. Pack contains 30 tablets, manufactured by Zydus Lifesciences Ltd. Storage instructions and safety warnings are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.